Company / EPS (Diluted)
Haemonetics EPS (Diluted) History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$2.29
FY2026
5-year range
$0.84 / $2.29
FY2022-FY2026
Trend
+2.2%
vs FY2025
Sector context
#54 of 159
Health Care
What the data says
At $2.29, Haemonetics's eps (diluted) ranks #54 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $-1.09 in FY2018 to $2.29 in FY2026.
Based on SEC 10-K filings.
2.29 in FY2026 with a 5-year CAGR of +22.2%.
Improved from $0.84 to $2.29 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +0.0%
- 5-Year CAGR
- +22.2%
- 10-Year CAGR
- -
Sector benchmark
#54 of 159 in Health CareTop 34% of 159This company $2.29 Sector average $1.67
▼
+37.3% above sector average
Key checks
Key Insights
- In FY2026, eps (diluted) increased 2.2% year-over-year.
- Ranks #54 out of 159 companies in the Health Care sector.
- Lowest eps (diluted) in the period was in FY2018.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2026 | $2.29 | +2.2% |
| FY2025 | $2.24 | +166.7% |
| FY2024 | $0.84 | -63.3% |
| FY2023 | $2.29 | +2.2% |
| FY2022 | $2.24 | +166.7% |
| FY2021 | $0.84 | -45.8% |
| FY2020 | $1.55 | +4.7% |
| FY2019 | $1.48 | +235.8% |
| FY2018 | -$1.09 | -440.6% |
| FY2017 | $0.32 | -52.2% |
As of FY2026 · SEC 10-K · Updated Jun 30, 2026